Baricitinib Blocks Cytokine-Mediated Downregulation of PAD1 in Human Keratinocytes: A Possible Molecular Link to the Effects of JAK Inhibitors in Atopic Dermatitis

J Invest Dermatol. 2023 Jul;143(7):1306-1309.e4. doi: 10.1016/j.jid.2022.12.012. Epub 2023 Jan 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytokines / metabolism
  • Dermatitis, Atopic* / drug therapy
  • Down-Regulation
  • Humans
  • Janus Kinase Inhibitors* / pharmacology
  • Janus Kinase Inhibitors* / therapeutic use
  • Keratinocytes / metabolism

Substances

  • Cytokines
  • Janus Kinase Inhibitors
  • baricitinib